Trade Compass Pathways PLC - ADR - CMPS CFD
What is Compass Pathways PLC - ADR (CMPS)?
Compass Pathways PLC is a mental health care company focused on the development and delivery of innovative therapies for treatment-resistant depression. The company specializes in the research and development of psychedelic-based therapeutics, particularly psilocybin therapy, which involves the use of psychoactive compounds in controlled clinical settings. Compass Pathways collaborates with academic institutions, regulatory agencies, and healthcare providers to advance clinical trials and regulatory approvals. Its approach integrates psychotherapy with pharmacological treatment to address mental health conditions. The company operates within the biotechnology and pharmaceutical sectors, emphasizing evidence-based innovation and patient safety. Compass Pathways aims to expand access to novel mental health treatments through rigorous scientific research and commercialization efforts.
Compass Pathways PLC - ADR Stock Price Today: Live Overview
The price today is shaped by active trading, with Structure Therapeutics Inc showing a current price of $5.64. Prices have fluctuated between $5.54 and $5.66 during the day, resulting in a daily change of +2.3723%.
FAQ: Compass Pathways PLC - ADR (CMPS)
What is the current price of CMPS stock?
The last price is $5.64.
Does CMPS pay dividends?
Compass Pathways PLC pays dividends via cash distributions (if applicable).
Does CMPS have a formal corporate presence or regional headquarters in the UAE?
Compass Pathways PLC has no official office or subsidiary in the UAE and operates through partners.
What is CMPS best known for?
The company is most famous for developing psychedelic therapies for mental health conditions.
What assets are typically shown together with CMPS?
Commonly shown alongside CMPS: Renault, Fidelity Financial, AerSale Corp
Latest shares articles



